Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Diabetes Mellitus, Type 2, Diabetes Education, Lifestyle Modification
About this trial
This is an interventional supportive care trial for Diabetes Mellitus, Type 2 focused on measuring Type 2 diabetes, Type II diabetes, uncontrolled type 2 diabetes, hyperglycemia, mobile web application, Diabetes education
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years Diagnosis of Type 2 Diabetes with HA1c >8.0 Current patients of the Family Healthcare Center, Reading Hospital Tower health. Exclusion Criteria: Identified special populations (pregnancy or individuals currently incarcerated) Patients without access to their own smart phone Any patient who is unable to provide their own informed consent to participate in the study
Sites / Locations
- Reading Hospital, an affiliate of Tower Health
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention arm
Control arm
Participants enrolled in the intervention arm will be given a 6-month access period to the diabetes education application designed by the study team. The web site will offer videos related to a specific areas of education concerning diabetes self-management. To encourage compliance, participant users will receive weekly notifications from the application that will guide them through viewing all videos in the series. Participants will continue routine follow-up appointments with their primary care physicians during the study period. There will be no restrictions on starting or stopping medications during the study period.
Participants in the control arm will not have access to the Diabetes Application. They will continue follow-up appointments according to the standard of care with their primary care physician, diabetic educators, etc. There are no restrictions on starting or stopping medications for patients within the control arm.